Home/Filings/4/0001144204-10-029303
4//SEC Filing

Fonstein Michael 4

Accession 0001144204-10-029303

CIK 0001318641other

Filed

May 19, 8:00 PM ET

Accepted

May 20, 4:34 PM ET

Size

7.7 KB

Accession

0001144204-10-029303

Insider Transaction Report

Form 4
Period: 2010-05-18
Fonstein Michael
DirectorCEO, President
Transactions
  • Award

    Employee Stock Options (Right to Buy)

    2010-05-18+105,000105,000 total
    Exercise: $3.44From: 2010-05-18Exp: 2020-05-17Common Stock (105,000 underlying)
Holdings
  • Employee Stock Options (Right to Buy)

    Exercise: $8.36From: 2007-04-06Exp: 2017-04-05Common Stock (37,500 underlying)
    37,500
  • Employee Stock Options (Right to Buy)

    Exercise: $4.00From: 2008-02-04Exp: 2018-02-03Common Stock (137,250 underlying)
    137,250

Documents

1 file

Issuer

CLEVELAND BIOLABS INC

CIK 0001318641

Entity typeother

Related Parties

1
  • filerCIK 0001369806

Filing Metadata

Form type
4
Filed
May 19, 8:00 PM ET
Accepted
May 20, 4:34 PM ET
Size
7.7 KB